Cargando…

Predictability of 21-Gene Recurrence Score Assay by Using Pathological and Immunohistochemical Parameters in Breast Cancer

BACKGROUND: Oncotype Dx is used to predict the long-term recurrence risk in patients with estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative invasive breast cancer (BC). This study aimed at establishing a correlation between clinicopathological parameters an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkushi, Abdulmohsen, Omair, Ahmad, Arabi, Haitham, Masuadi, Emad, Abualkhair, Omalkhair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727040/ https://www.ncbi.nlm.nih.gov/pubmed/33343196 http://dx.doi.org/10.1177/1178223420977848

Ejemplares similares

Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
por: Omair, Ahmad, et al.
Publicado: (2023)

The Level of Agreement Among Medical Oncologists on Adjuvant Chemotherapy Decision for Breast Cancer in Pre and Post-Oncotype DX Settings
por: Alkushi, Abdulmohsen, et al.
Publicado: (2021)

Breast cancer in women younger than 30 years: prevalence rate and imaging findings in a symptomatic population
por: Makanjuola, Dorothy, et al.
Publicado: (2014)

Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay—Results From the SAFIA Phase III Trial
por: AlSaleh, Khalid, et al.
Publicado: (2021)

Primary Uterine Rhabdomyosarcoma in a 54-Year-Old Postmenopausal Woman
por: Aljehani, Ala M, et al.
Publicado: (2020)

Preoperative diagnosis of hydatid cyst of the breast: a case report
por: Alamer, Ali, et al.
Publicado: (2013)

Surgeon and medical oncologist peer network effects on the uptake of the 21‐gene breast cancer recurrence score assay
por: Zipkin, Ronnie, et al.
Publicado: (2021)

The 21-Gene Recurrence Score Assay and Prediction of Chemotherapy Benefit: A Propensity Score-Matched Analysis of the SEER Database
por: Choi, In Sil, et al.
Publicado: (2020)

Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma
por: Yenidunya, Sibel, et al.
Publicado: (2011)

Uterine Myxoid Tumor: A Case Report on a Mysterious and Unexpected Diagnosis
por: Khubrani, Reham A, et al.
Publicado: (2023)

The Role of the 21-Gene Recurrence Score(®) Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience
por: Yordanova, Mariya, et al.
Publicado: (2022)

Trends in the Usage of Statistical Software and Their Associated Study Designs in Health Sciences Research: A Bibliometric Analysis
por: Masuadi, Emad, et al.
Publicado: (2021)

BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score
por: Zarella, Mark D., et al.
Publicado: (2018)

Performance of Automated Dissection on Formalin-Fixed Paraffin-Embedded Tissue Sections for the 21-Gene Recurrence Score Assay
por: Qi, Peng, et al.
Publicado: (2020)

A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer
por: Frazier, Thomas G., et al.
Publicado: (2015)

Clinical relevance of the 21-gene Recurrence Score(®) assay in treatment decisions for patients with node-positive breast cancer in the genomic era
por: Mamounas, Eleftherios P., et al.
Publicado: (2018)

Measurement of Exam Anxiety Levels Among Medical Students and Their Association With the Influencing Factors
por: Memon, Ismail, et al.
Publicado: (2023)

Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
por: Jiang, Peng, et al.
Publicado: (2020)

21-Gene Recurrence Score Assay and Outcomes of Adjuvant Radiotherapy in Elderly Women With Early-Stage Breast Cancer After Breast-Conserving Surgery
por: Wu, San-Gang, et al.
Publicado: (2019)

Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)

Morphometrical and Immunohistochemical Evaluation of Kidney as an Indirect Parameter to Estimate Age in Puppies in Veterinary Forensic Pathology
por: d’Aquino, Ilaria, et al.
Publicado: (2023)

Comparison of CTS5 risk model and 21-gene recurrence score assay in large-scale breast cancer population and combination of CTS5 and recurrence score to develop a novel nomogram for prognosis prediction
por: Wang, Changjun, et al.
Publicado: (2022)

Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65
por: O’Neill, Suzanne C., et al.
Publicado: (2017)

Impact of the 21-Gene Recurrence Score Assay on Treatment Decisions and Cost in Patients with Node-Positive Breast Cancer: A Multicenter Study in Quebec
por: Hassan, Saima, et al.
Publicado: (2022)

Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS
por: Sulayman, Nadiyah, et al.
Publicado: (2012)

Racial differences in predictive value of the 21-gene recurrence score assay: a population-based study using the SEER database
por: Jung, Jiwoong, et al.
Publicado: (2022)

BREAST CANCER IN YOUNG WOMEN: PATHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES
por: Erić, Ivan, et al.
Publicado: (2018)

The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016)

Association between Depression and Factors Affecting Career Choice among Jordanian Nursing Students
por: Yousef, Said, et al.
Publicado: (2017)

Future ophthalmology practice pattern: A survey of Saudi Board of Ophthalmology residents
por: Al-Essa, Rakan S., et al.
Publicado: (2019)

The use of olive oil for skin health in a Saudi population: A cross-sectional study
por: Alnemer, Faisal, et al.
Publicado: (2021)

Vulvar Leiomyosarcoma in Pregnancy
por: Aljehani, Ala M, et al.
Publicado: (2021)

Distribution of the 21-Gene Breast Recurrence Score in Patients with Primary Breast Cancer in Germany
por: Walter, Vincent P., et al.
Publicado: (2020)

Decision-making of Adjuvant Chemotherapy for Breast Cancer Patients with Discordant Risk Classifications between Clinical-Pathological Factors and 21-gene Recurrence Score
por: Gao, Weiqi, et al.
Publicado: (2020)

Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer
por: Chae, Eun Young, et al.
Publicado: (2016)

Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence
por: Howard, Frederick M., et al.
Publicado: (2023)

Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients
por: Lu, Yujie, et al.
Publicado: (2020)

Prevalence, Risk Factors, and Outcomes of Platelet Transfusion Refractoriness in Critically Ill Patients: A Retrospective Cohort Study
por: Arabi, Saeed, et al.
Publicado: (2021)

Systematic evaluation of scoring methods for Ki67 as a surrogate for 21-gene recurrence score
por: Paik, Soonmyung, et al.
Publicado: (2021)

Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay
por: Ahn, Sung Gwe, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1hp7frrqftjo1fnff3f9ujr6ku